Cargando…
Gene expression profiling to predict responsiveness to immunotherapy
Recent clinical successes with immunotherapy have resulted in expanding indications for cancer therapy. To enhance anti-tumor immune responses, and to better choose specific strategies matched to patient and tumor characteristics, genomic-driven precision immunotherapy will be necessary. Herein, we...
Autores principales: | Jamieson, Nigel B., Maker, Ajay V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386795/ https://www.ncbi.nlm.nih.gov/pubmed/27834354 http://dx.doi.org/10.1038/cgt.2016.63 |
Ejemplares similares
-
The Evolution of Cancer Immunotherapy
por: Khan, Meshaal, et al.
Publicado: (2021) -
Gene Expression Profiles Accurately Predict Outcome Following Liver Resection in Patients with Metastatic Colorectal Cancer
por: Ito, Hiromichi, et al.
Publicado: (2013) -
The Potential of Intralesional Rose Bengal to Stimulate T-Cell Mediated Anti-Tumor Responses
por: Maker, Ajay V, et al.
Publicado: (2015) -
Serine and glycine metabolism-related gene expression signature stratifies immune profiles of brain gliomas, and predicts prognosis and responses to immunotherapy
por: Chen, Siliang, et al.
Publicado: (2022) -
LIGHT enhanced bispecific antibody armed T-cells to treat immunotherapy resistant colon cancer
por: Qiao, Guilin, et al.
Publicado: (2022)